全文获取类型
收费全文 | 1351篇 |
免费 | 61篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 63篇 |
妇产科学 | 19篇 |
基础医学 | 120篇 |
口腔科学 | 27篇 |
临床医学 | 138篇 |
内科学 | 367篇 |
皮肤病学 | 109篇 |
神经病学 | 35篇 |
特种医学 | 207篇 |
外科学 | 120篇 |
综合类 | 30篇 |
预防医学 | 81篇 |
眼科学 | 6篇 |
药学 | 42篇 |
中国医学 | 3篇 |
肿瘤学 | 47篇 |
出版年
2021年 | 9篇 |
2019年 | 9篇 |
2018年 | 9篇 |
2017年 | 12篇 |
2016年 | 16篇 |
2015年 | 23篇 |
2014年 | 28篇 |
2013年 | 76篇 |
2012年 | 16篇 |
2011年 | 15篇 |
2010年 | 48篇 |
2009年 | 58篇 |
2008年 | 23篇 |
2007年 | 30篇 |
2006年 | 26篇 |
2005年 | 31篇 |
2004年 | 16篇 |
2003年 | 13篇 |
2002年 | 23篇 |
2001年 | 20篇 |
2000年 | 14篇 |
1999年 | 22篇 |
1998年 | 84篇 |
1997年 | 73篇 |
1996年 | 77篇 |
1995年 | 49篇 |
1994年 | 62篇 |
1993年 | 51篇 |
1992年 | 15篇 |
1991年 | 15篇 |
1990年 | 21篇 |
1989年 | 43篇 |
1988年 | 42篇 |
1987年 | 32篇 |
1986年 | 27篇 |
1985年 | 27篇 |
1984年 | 23篇 |
1983年 | 14篇 |
1982年 | 23篇 |
1981年 | 19篇 |
1980年 | 13篇 |
1979年 | 19篇 |
1978年 | 15篇 |
1977年 | 18篇 |
1976年 | 17篇 |
1975年 | 13篇 |
1973年 | 14篇 |
1972年 | 9篇 |
1971年 | 7篇 |
1957年 | 7篇 |
排序方式: 共有1445条查询结果,搜索用时 78 毫秒
991.
992.
993.
994.
Fibrillin-1 (FBN1) gene frameshift mutations in Marfan patients: genotype–phenotype correlation 总被引:1,自引:0,他引:1
G Pepe B Giusti L Evangelisti MC Porciani T Brunelli L Giurlani M Attanasio R Fattori C Bagni P Comeglio R Abbate GF Gensini 《Clinical genetics》2001,59(6):444-450
Marfan syndrome (MFS) is a multisystemic disease associated with mutations in the fibrillin-1 gene. Most of the reported mutations are missense substitutions mainly affecting the epidermal growth factor (EGF)-like protein domain structure and the calcium-binding (cb) site. The aim of our study was to investigate the correlation between fibrillin-1 frameshift mutations and the clinical phenotype in patients affected by MFS. In 48 out of 66 Marfan patients a pathogenetic mutation was found. We detected novel mutations causing premature termination codon in exons 19, 37, 40 and 41 of four Italian patients. The first mutation in exon 19 (cbEGF #8 domain) results in a clinical phenotype involving mainly the skeletal and cardiovascular systems. Interestingly, we noticed that, while mutations in exons 37 and 41 (eight cysteine domains #4 and #5) are milder, the mutation in exon 40 (cbEGF #24 domain) is more severe and causes major cardiovascular involvement with thoracic and abdominal aortic aneurysms. It is noteworthy that the degree of the severity in the phenotype of one of our patients and another from the literature carrying a mutation in exon 41 could be explained with alterations in mRNA expression. 相似文献
995.
996.
997.
998.
Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma 总被引:7,自引:0,他引:7
Ryoo MC; Kagan AR; Wollin M; Tome MA; Tedeschi MA; Rao AR; Hintz BL; Kuruvilla AM; Nussbaum H; Streeter OE Jr 《Radiology》1989,172(2):555-559
Between 1978 and 1985, 393 of 2,765 (14%) patients with operable cancer of the breast (clinical stage T0-3N0-2M0) were irradiated after excisional biopsy and staging axillary dissection. Of 77 patients with microscopic axillary metastases, 68 received systemic adjuvant therapy. Treatment failed locally in 26 cases, and there were seven patients with distant metastasis. The three major factors for increased local treatment failure were (a) age below 40 years (P = .003), (b) negative estrogen receptor assay result (P = .03), and (c) failure to deliver a radiation boost dose when tumor was present at the margin of the specimen (P = .002). The size of the tumor, the nodal status, the progesterone receptor assay result, and the presence of ductal carcinoma in situ mixed with infiltrating carcinoma did not show a significant influence on local recurrence. In 274 of 393 (70%) patients, cosmesis was evaluated. The four major factors affecting cosmesis favorably were (a) utilization of a wedge (P less than .0001); (b) treatment of two fields a day (P less than .0001); (c) failure to use a separate treatment port to the regional lymph nodes, so as to avoid field junctions (P = .0003); and (d) small size of specimen (less than 50 cm2) (P = .0171). A second or third cancer was found in 39 of the 393 (10%) patients; contralateral breast cancer was the most common form (n = 23), followed by genitourinary cancer (n = 5). The most frequent complication was arm edema (6%). 相似文献
999.
1000.
CYP2D6和GST在白种人晚期肾病中的遗传变异 总被引:1,自引:0,他引:1
目的生物转化酶细胞色素P4502D6(CYP2D6)和谷胱苷肽转移酶-M1(GST-M1)、谷胱苷肽转移酶-T1(GST-T1)共同代谢内源性和外源性毒素,一部分人群由于相应基因变异导致这些酶缺乏表达,我们检测白种人群中晚期肾病(ESRD)病人这些酶的基因多态性是否比健康者有较高的频率.方法从列克星顿及周围地区征募330名晚期肾病病人和303名健康者,均为白种人,给予他们进行CYP2D6和GST-M1和T1基因分型.结果在ESRD病人中CYP2D6和GST-M1和GST-T1以及CYP2D6和GST-M1或GST-T1都缺乏分别为2.1%和4.2%;而在健康者中均为0.3%(P<0.01).结论CYP2D6和GST-M1和/或GST-T1酶缺乏在ESRD病人中有较高的频率,提示这些酶缺乏可以预计慢性肾病进展的可能性. 相似文献